相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis
Chen Chen et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2020)
被撤回的出版物: Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3 (Retracted article. See vol. 549, 2022)
Wei Zhang et al.
CANCER LETTERS (2020)
Down-regulation of circ-PTN suppresses cell proliferation, invasion and glycolysis in glioma by regulating miR-432-5p/RAB10 axis
Xinyu Zhang et al.
NEUROSCIENCE LETTERS (2020)
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer
Jingwei Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Xiaoxu Huang et al.
MOLECULAR CANCER (2019)
circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma
Jiansheng Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5
Shuai Zhang et al.
NEURO-ONCOLOGY (2019)
Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
Ruiqi Lu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer
Hui Lyu et al.
CANCER LETTERS (2018)
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling
Jing Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Emerging role of long non-coding RNAs in cisplatin resistance
Yang Hu et al.
ONCOTARGETS AND THERAPY (2018)
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Eroje M. Ahmed et al.
CELLULAR ONCOLOGY (2018)
Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway
Pedro Nicolau-Neto et al.
Oncotarget (2018)
Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1 pathway
Weiyi Huang et al.
NEUROREPORT (2018)
Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K/AKT/mTOR and DNA damage response pathways
Yingying Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 MiR-152-3p regulate glioma cell apoptosis and invasion
Jin Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2
Bin Liu et al.
LIFE SCIENCES (2017)
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
Yu Wang et al.
MEDICINE (2017)
Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy
Binbin Ma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Antitumour action on human glioblastoma A1235 cells through cooperation of bee venom and cisplatin
Goran Gajski et al.
CYTOTECHNOLOGY (2016)
Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016
Bastian Malzkorn et al.
CURRENT OPINION IN ONCOLOGY (2016)
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
Franceli Rodrigues Kulcheski et al.
JOURNAL OF BIOTECHNOLOGY (2016)
Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide
Masashi Mizumoto et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy
Xiangyu Liu et al.
NEUROSCIENCE LETTERS (2016)
Circular RNA profile in gliomas revealed by identification tool UROBORUS
Xiaofeng Song et al.
NUCLEIC ACIDS RESEARCH (2016)
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
Xiaoman Li et al.
ONCOTARGET (2016)
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma
Nathan B. Roberts et al.
ONCOIMMUNOLOGY (2016)
MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma
Junchao Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line
Shaorong Han et al.
MOLECULAR MEDICINE REPORTS (2015)
Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Meena Jhanwar-Uniyal et al.
CANCERS (2015)
Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library
Jin Zhou et al.
BMC MEDICAL GENOMICS (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Michela Garofalo et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death
Hong-Gang Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
分享论文
